Collagen's Second-Quarter Results
Also at the conference, Howard Palefsky, president and chiefexecutive officer of Collagen Corp. (NASDAQ:CGEN) of Palo Alto,Calif., announced the company's estimated second-quarterfinancial results.
For the quarter ended December 31, 1993, the companyexpects earnings of 11 to 13 cents per share on revenues of$16.5-17 million. Second-quarter revenues from the company'sContigen Bard Collagen Implant for the treatment of urinaryincontinence will be about $4 million, he added. Sales of thecompany's other products "should fall within the range ofanalysts' estimates."011293H&Q
-- By Brenda Sandburg News Editor